Clinical Applications


Micropoint's rapid point-of-care and home test products span a range of clinical applications for medical teams seeking to expedite diagnosis and evaluation where accuracy and early intervention is critical. These life-threatening diseases burden society with mounting healthcare costs in the hundreds of billions per year. Micropoint's point-of-care diagnostic tests help lower costs by quickly detecting conditions and events early -- in hospital, or at home through self-testing -- so that medical teams can determine the most effective preventive therapy and get patients back to their lifestyles. 


We have strong expertise in cardiovascular disease diagnostics and assessment. including heart failure, myocardial infarctions, and embolisms. We provide a range of tests for anticoagulants used in stroke, heart attack and venous thromboembolisms, including deep vein thrombosis (DVT) and pulmonary embolisms (PE). Our tests for sepsis and severe systemic bacterials infections enable medical teams to differentiate between infection types. 




U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.